SCHEMBL14428845

SCHEMBL14428845

CNCCC(=O)n1cnc2cnccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.38
ASAH1 Q13510 6/20 0.36
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
CYP2C9 P11712 1/20 0.35
IDO1 P14902 1/20 0.35
KCNH2 Q12809 1/20 0.35
LTA4H P09960 1/20 0.34
TRPA1 O75762 1/20 0.33
ACHE P22303 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNA4 P43681 1/20 0.33
JAK2 O60674 1/20 0.32
JAK3 P52333 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27599900 0.79 FGFR1 (0.43) FGFR1ASAH1MKNK1MKNK2CYP2C9
SCHEMBL14428842 0.77 SLC22A12 (0.46) MKNK2
SCHEMBL4910691 0.76 FGFR1 (0.43) FGFR1ASAH1CYP2C9IDO1KCNH2
SCHEMBL30622656 0.75 FGFR1 (0.51) FGFR1ASAH1MKNK1MKNK2LTA4H
SCHEMBL5030414 0.73 FGFR1 (0.46) FGFR1ASAH1MKNK1MKNK2CYP2C9
SCHEMBL29795658 0.69 ASAH1 (0.63) FGFR1ASAH1CYP2C9TRPA1NPC1
SCHEMBL31229358 0.69 KMT2A (0.55) FGFR1ASAH1LTA4HNPC1ALDH1A1
SCHEMBL27582500 0.67 LTA4H (0.35) FGFR1ASAH1CYP2C9IDO1KCNH2
SCHEMBL10640921 0.67 LTA4H (0.44) LTA4HALDH1A1MAPTHPGD
SCHEMBL15156816 0.65 FGFR1 (0.47) FGFR1CYP2C9LTA4HNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070191420-A1 Kinase inhibitors DEVGEN NV 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191420-A1 Kinase inhibitors ROCK1, ROCK2, MAP3K20 FGFR1 793/4885ASAH1 1357/4885MKNK1 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.